The Medicines Patent Pool Signs First Sub-licences for Hepatitis C Medicine Daclatasvir
Four companies to help speed access to curative direct-acting antiviral in 112 low- and middle-income countries [MPP Press release, Link, (CC-BY-NC-ND)] Geneva, 20 January 2016 – The Medicines Patent Pool (MPP) announced its first round of sub-licences for the generic…
